Medacta Group SA (MOVE) - Total Liabilities
Based on the latest financial reports, Medacta Group SA (MOVE) has total liabilities worth CHF436.15 Million CHF (≈ $551.42 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Medacta Group SA cash flow conversion to assess how effectively this company generates cash.
Medacta Group SA - Total Liabilities Trend (2015–2024)
This chart illustrates how Medacta Group SA's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Medacta Group SA to evaluate the company's liquid asset resilience ratio.
Medacta Group SA Competitors by Total Liabilities
The table below lists competitors of Medacta Group SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Seacoast Banking Corporation of Florida
NASDAQ:SBCF
|
USA | $17.79 Billion |
|
Community Bank System Inc
NYSE:CBU
|
USA | $15.41 Billion |
|
Hawkins Inc
NASDAQ:HWKN
|
USA | $457.62 Million |
|
Guangdong Dongfang Precision Science & Technology Co Ltd
SHE:002611
|
China | CN¥2.76 Billion |
|
Sunrun Inc
NASDAQ:RUN
|
USA | $19.19 Billion |
|
Quilter PLC
JSE:QLT
|
South Africa | ZAC75.08 Billion |
|
Lakala Payment Co Ltd
SHE:300773
|
China | CN¥7.11 Billion |
|
Telefonaktiebolaget LM Ericsson (publ)
ST:ERIC-A
|
Sweden | Skr168.96 Billion |
Liability Composition Analysis (2015–2024)
This chart breaks down Medacta Group SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Medacta Group SA stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.39 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medacta Group SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medacta Group SA (2015–2024)
The table below shows the annual total liabilities of Medacta Group SA from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CHF412.51 Million ≈ $521.53 Million |
+12.76% |
| 2023-12-31 | CHF365.83 Million ≈ $462.51 Million |
+18.07% |
| 2022-12-31 | CHF309.83 Million ≈ $391.71 Million |
+17.87% |
| 2021-12-31 | CHF262.87 Million ≈ $332.34 Million |
-5.18% |
| 2020-12-31 | CHF277.22 Million ≈ $350.48 Million |
-4.19% |
| 2019-12-31 | CHF289.33 Million ≈ $365.79 Million |
+4.63% |
| 2018-12-31 | CHF276.53 Million ≈ $349.60 Million |
+39.56% |
| 2017-12-31 | CHF198.14 Million ≈ $250.50 Million |
+61.34% |
| 2016-12-31 | CHF122.81 Million ≈ $155.27 Million |
+11.35% |
| 2015-12-31 | CHF110.29 Million ≈ $139.44 Million |
-- |
About Medacta Group SA
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.